INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 285 filers reported holding INTELLIA THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 1.94 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $10,398 | – | 279 | – | 0.00% | – |
| Q4 2022 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
| Q3 2022 | $1,000 | – | 21 | +133.3% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 9 | -73.5% | 0.00% | – |
| Q1 2022 | $2,000 | -50.0% | 34 | -8.1% | 0.00% | – |
| Q4 2021 | $4,000 | -55.6% | 37 | -46.4% | 0.00% | -100.0% |
| Q3 2021 | $9,000 | 0.0% | 69 | +27.8% | 0.00% | 0.0% |
| Q2 2021 | $9,000 | +28.6% | 54 | -40.7% | 0.00% | 0.0% |
| Q1 2021 | $7,000 | +250.0% | 91 | +102.2% | 0.00% | – |
| Q4 2020 | $2,000 | +100.0% | 45 | +73.1% | 0.00% | – |
| Q3 2020 | $1,000 | – | 26 | +44.4% | 0.00% | – |
| Q2 2020 | $0 | – | 18 | -14.3% | 0.00% | – |
| Q1 2020 | $0 | -100.0% | 21 | -63.8% | 0.00% | – |
| Q4 2019 | $1,000 | – | 58 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darwin Global Management, Ltd. | 752,024 | $100,884,000 | 18.57% |
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 420,859 | $56,458,000 | 4.40% |
| Discovery Value Fund | 922,411 | $123,741,000 | 3.63% |
| MPM BioImpact LLC | 162,620 | $21,815,000 | 3.38% |
| Ally Bridge Group (NY) LLC | 65,000 | $8,720,000 | 2.56% |
| ARK Investment Management | 6,743,556 | $904,648,000 | 2.17% |
| Integral Health Asset Management, LLC | 50,000 | $6,708,000 | 1.93% |
| Yorktown Management & Research Co Inc | 18,300 | $2,455,000 | 1.85% |
| Interchange Capital Partners, LLC | 8,191 | $1,098,000 | 1.84% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 111,440 | $14,950,000 | 1.76% |